Activation of ERK accelerates repair of renal tubular epithelial cells, whereas it inhibits progression of fibrosis following ischemia/reperfusion injury

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1832, Issue 12, 2013, Pages 1998-2008

  Jang, Hee Seong ^a   Han, Sang Jun ^a   Kim, Jee In ^a   Lee, Sanggyu ^b   Lipschutz, Joshua H ^c   Park, Kwon Moo ^a  

^a Kyungpook National University School of Medicine   (South Korea)

^b Kyungpook National University   (South Korea)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Exocyst; Ischemia; Mitogen activated protein kinase; Primary cilium; Proliferation; Regeneration

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); MITOGEN ACTIVATED PROTEIN KINASE;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE COURSE; ENZYME INHIBITION; EPITHELIUM CELL; EUKARYOTIC FLAGELLUM; EXTRACELLULAR MATRIX; KIDNEY FIBROSIS; LEYDIG CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION INJURY;

EID: 84882807441     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2013.07.001     Document Type: Article

References (56)

1. Hsu C.Y., McCulloch C.E., Fan D., Ordonez J.D., Chertow G.M., Go A.S. Community-based incidence of acute renal failure. Kidney Int. 2007, 72:208-212.
2. Hoste E.A., Clermont G., Kersten A., Venkataraman R., Angus D.C., De Bacquer D., Kellum J.A. RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis. Crit. Care 2006, 10:R73.
3. Chertow G.M., Burdick E., Honour M., Bonventre J.V., Bates D.W. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J. Am. Soc. Nephrol. 2005, 16:3365-3370.
4. Thadhani R., Pascual M., Bonventre J.V. Acute renal failure. N. Engl. J. Med. 1996, 334:1448-1460.
5. Bonventre J.V., Yang L. Cellular pathophysiology of ischemic acute kidney injury. J. Clin. Invest. 2011, 121:4210-4221.
6. Kim J., Jung K.J., Park K.M. Reactive oxygen species differently regulate renal tubular epithelial and interstitial cell proliferation after ischemia and reperfusion injury. Am. J. Physiol. Renal Physiol. 2010, 298:F1118-F1129.
7. Kim E.K., Choi E.J. Pathological roles of MAPK signaling pathways in human diseases. Biochim. Biophys. Acta 2010, 1802:396-405.
8. Tian W., Zhang Z., Cohen D.M. MAPK signaling and the kidney. Am. J. Physiol. Renal Physiol. 2000, 279:F593-F604.
9. Johnson G.L., Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 2002, 298:1911-1912.
10. Park K.M., Chen A., Bonventre J.V. Prevention of kidney ischemia/reperfusion-induced functional injury and JNK, p38, and MAPK kinase activation by remote ischemic pretreatment. J. Biol. Chem. 2001, 276:11870-11876.
11. Jang H.S., Kim J.I., Kim J., Na Y.K., Park J.W., Park K.M. Bone marrow derived cells and reactive oxygen species in hypertrophy of contralateral kidney of transient unilateral renal ischemia-induced mouse. Free Radic. Res. 2012, 46:903-911.
12. Jang H.S., Kim J., Kim K.Y., Kim J.I., Cho M.H., Park K.M. Previous ischemia and reperfusion injury results in resistance of the kidney against subsequent ischemia and reperfusion insult in mice; a role for the Akt signal pathway. Nephrol. Dial. Transplant. 2012, 27:3762-3770.
13. Kim J., Seok Y.M., Jung K.J., Park K.M. Reactive oxygen species/oxidative stress contributes to progression of kidney fibrosis following transient ischemic injury in mice. Am. J. Physiol. Renal Physiol. 2009, 297:F461-F470.
14. Jang H.S., Kim J., Park Y.K., Park K.M. Infiltrated macrophages contribute to recovery after ischemic injury but not to ischemic preconditioning in kidneys. Transplantation 2008, 85:447-455.
15. Park K.M., Kramers C., Vayssier-Taussat M., Chen A., Bonventre J.V. Prevention of kidney ischemia/reperfusion-induced functional injury, MAPK and MAPK kinase activation, and inflammation by remote transient ureteral obstruction. J. Biol. Chem. 2002, 277:2040-2049.
16. Zuo X., Guo W., Lipschutz J.H. The exocyst protein Sec10 is necessary for primary ciliogenesis and cystogenesis in vitro. Mol. Biol. Cell 2009, 20:2522-2529.
17. Kim J., Kim J.I., Na Y.K., Park K.M. Intra-renal slow cell-cycle cells contribute to the restoration of kidney tubules injured by ischemia/reperfusion. Anal. Cell Biol. 2011, 44:186-193.
18. Nielsen J., Kwon T.H., Masilamani S., Beutler K., Hager H., Nielsen S., Knepper M.A. Sodium transporter abundance profiling in kidney: effect of spironolactone. Am. J. Physiol. Renal Physiol. 2002, 283:F923-F933.
19. Fujimoto T., Fujigaki Y., Sun D.F., Togawa A., Yonemura K., Hishida A. Important role for fibronectin-EIIIA during renal tubular repair and cellular recovery in uranyl acetate-induced acute renal failure of rats. Virchows Arch. 2003, 443:194-205.
20. Petrini G., Ochoa E.J., Serra E., Torres A.M., Elias M.M. Fibronectin expression in proximal tubules from ischemic rat kidneys without reperfusion. Mol. Cell. Biochem. 2002, 241:21-27.
21. To W.S., Midwood K.S. Plasma and cellular fibronectin: distinct and independent functions during tissue repair. Fibrogenesis Tissue Repair 2011, 4:21.
22. Harper J.W., Adami G.R., Wei N., Keyomarsi K., Elledge S.J. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 1993, 75:805-816.
23. Prunotto M., Budd D.C., Gabbiani G., Meier M., Formentini I., Hartmann G., Pomposiello S., Moll S. Epithelial-mesenchymal crosstalk alteration in kidney fibrosis. J. Pathol. 2012, 228:131-147.
24. Shankland S.J., Wolf G. Cell cycle regulatory proteins in renal disease: role in hypertrophy, proliferation, and apoptosis. Am. J. Physiol. Renal Physiol. 2000, 278:F515-F529.
25. Yang L., Besschetnova T.Y., Brooks C.R., Shah J.V., Bonventre J.V. Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury. Nat. Med. 2010, 16:535-543. (531 pp. following 143).
26. Megyesi J., Price P.M., Tamayo E., Safirstein R.L. The lack of a functional p21(WAF1/CIP1) gene ameliorates progression to chronic renal failure. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:10830-10835.
27. Rajasekaran S.A., Palmer L.G., Moon S.Y., Peralta Soler A., Apodaca G.L., Harper J.F., Zheng Y., Rajasekaran A.K. Na,K-ATPase activity is required for formation of tight junctions, desmosomes, and induction of polarity in epithelial cells. Mol. Biol. Cell 2001, 12:3717-3732.
28. Verghese E., Weidenfeld R., Bertram J.F., Ricardo S.D., Deane J.A. Renal cilia display length alterations following tubular injury and are present early in epithelial repair. Nephrol. Dial. Transplant. 2008, 23:834-841.
29. Park K.M., Fogelgren B., Zuo X., Kim J., Chung D.C., Lipschutz J.H. Exocyst Sec10 protects epithelial barrier integrity and enhances recovery following oxidative stress, by activation of the MAPK pathway. Am. J. Physiol. Renal Physiol. 2010, 298:F818-F826.
30. Humphreys B.D., Czerniak S., DiRocco D.P., Hasnain W., Cheema R., Bonventre J.V. Repair of injured proximal tubule does not involve specialized progenitors. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:9226-9231.
31. Humphreys B.D., Valerius M.T., Kobayashi A., Mugford J.W., Soeung S., Duffield J.S., McMahon A.P., Bonventre J.V. Intrinsic epithelial cells repair the kidney after injury. Cell Stem Cell 2008, 2:284-291.
32. Bonventre J.V. Dedifferentiation and proliferation of surviving epithelial cells in acute renal failure. J. Am. Soc. Nephrol. 2003, 14(Suppl. 1):S55-S61.
33. di Mari J.F., Davis R., Safirstein R.L. MAPK activation determines renal epithelial cell survival during oxidative injury. Am. J. Physiol. 1999, 277:F195-F203.
34. An W.S., Kim H.J., Cho K.H., Vaziri N.D. Omega-3 fatty acid supplementation attenuates oxidative stress, inflammation, and tubulointerstitial fibrosis in the remnant kidney. Am. J. Physiol. Renal Physiol. 2009, 297:F895-F903.
35. Chao J., Li H.J., Yao Y.Y., Shen B., Gao L., Bledsoe G., Chao L. Kinin infusion prevents renal inflammation, apoptosis, and fibrosis via inhibition of oxidative stress and mitogen-activated protein kinase activity. Hypertension 2007, 49:490-497.
36. Kurian S.M., Heilman R., Mondala T.S., Nakorchevsky A., Hewel J.A., Campbell D., Robison E.H., Wang L., Lin W., Gaber L., Solez K., Shidban H., Mendez R., Schaffer R.L., Fisher J.S., Flechner S.M., Head S.R., Horvath S., Yates J.R., Marsh C.L., Salomon D.R. Biomarkers for early and late stage chronic allograft nephropathy by proteogenomic profiling of peripheral blood. PLoS One 2009, 4:e6212.
37. Otterbein L.E., Bach F.H., Alam J., Soares M., Tao Lu H., Wysk M., Davis R.J., Flavell R.A., Choi A.M. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat. Med. 2000, 6:422-428.
38. Chen J., Chen J.K., Harris R.C. Deletion of the epidermal growth factor receptor in renal proximal tubule epithelial cells delays recovery from acute kidney injury. Kidney Int. 2012, 82:45-52.
39. Na H.K., Kim E.H., Jung J.H., Lee H.H., Hyun J.W., Surh Y.J. (-)-Epigallocatechin gallate induces Nrf2-mediated antioxidant enzyme expression via activation of PI3K and ERK in human mammary epithelial cells. Arch. Biochem. Biophys. 2008, 476:171-177.
40. Xu D., Guthrie J.R., Mabry S., Sack T.M., Truog W.E. Mitochondrial aldehyde dehydrogenase attenuates hyperoxia-induced cell death through activation of ERK/MAPK and PI3K-Akt pathways in lung epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 2006, 291:L966-L975.
41. Maeng Y.S., Min J.K., Kim J.H., Yamagishi A., Mochizuki N., Kwon J.Y., Park Y.W., Kim Y.M., Kwon Y.G. ERK is an anti-inflammatory signal that suppresses expression of NF-kappaB-dependent inflammatory genes by inhibiting IKK activity in endothelial cells. Cell. Signal. 2006, 18:994-1005.
42. Jo S.K., Cho W.Y., Sung S.A., Kim H.K., Won N.H. MEK inhibitor, U0126, attenuates cisplatin-induced renal injury by decreasing inflammation and apoptosis. Kidney Int. 2005, 67:458-466.
43. Dunbar L.A., Caplan M.J. Ion pumps in polarized cells: sorting and regulation of the Na+, K+- and H+, K+-ATPases. J. Biol. Chem. 2001, 276:29617-29620.
44. Rajasekaran S.A., Huynh T.P., Wolle D.G., Espineda C.E., Inge L.J., Skay A., Lassman C., Nicholas S.B., Harper J.F., Reeves A.E., Ahmed M.M., Leatherman J.M., Mullin J.M., Rajasekaran A.K. Na,K-ATPase subunits as markers for epithelial-mesenchymal transition in cancer and fibrosis. Mol. Cancer Ther. 2010, 9:1515-1524.
45. Verghese E., Ricardo S.D., Weidenfeld R., Zhuang J., Hill P.A., Langham R.G., Deane J.A. Renal primary cilia lengthen after acute tubular necrosis. J. Am. Soc. Nephrol. 2009, 20:2147-2153.
46. Liu Z., Greco A.J., Hellman N.E., Spector J., Robinson J., Tang O.T., Lipschutz J.H. Intracellular signaling via ERK/MAPK completes the pathway for tubulogenic fibronectin in MDCK cells. Biochem. Biophys. Res. Commun. 2007, 353:793-798.
47. Hellman N.E., Greco A.J., Rogers K.K., Kanchagar C., Balkovetz D.F., Lipschutz J.H. Activated extracellular signal-regulated kinases are necessary and sufficient to initiate tubulogenesis in renal tubular MDCK strain I cell cysts. Am. J. Physiol. Renal Physiol. 2005, 289:F777-F785.
48. Zuo X., Fogelgren B., Lipschutz J.H. The small GTPase Cdc42 is necessary for primary ciliogenesis in renal tubular epithelial cells. J. Biol. Chem. 2011, 286:22469-22477.
49. Lipschutz J.H., Guo W., O'Brien L.E., Nguyen Y.H., Novick P., Mostov K.E. Exocyst is involved in cystogenesis and tubulogenesis and acts by modulating synthesis and delivery of basolateral plasma membrane and secretory proteins. Mol. Biol. Cell 2000, 11:4259-4275.
50. Zeisberg M., Neilson E.G. Mechanisms of tubulointerstitial fibrosis. J. Am. Soc. Nephrol. 2010, 21:1819-1834.
51. Ponnusamy M., Liu N., Gong R., Yan H., Zhuang S. ERK pathway mediates P2X7 expression and cell death in renal interstitial fibroblasts exposed to necrotic renal epithelial cells. Am. J. Physiol. Renal Physiol. 2011, 301:F650-F659.
52. Seeger-Nukpezah T., Golemis E.A. The extracellular matrix and ciliary signaling. Curr. Opin. Cell Biol. 2012, 24:652-661.
53. Chuang P.Y., Menon M.C., He J.C. Molecular targets for treatment of kidney fibrosis. J. Mol. Med. (Berl) 2013, 91:549-559.
54. Copeland J.W., Beaumont B.W., Merrilees M.J., Pilmore H.L. Epithelial-to-mesenchymal transition of human proximal tubular epithelial cells: effects of rapamycin, mycophenolate, cyclosporin, azathioprine, and methylprednisolone. Transplantation 2007, 83:809-814.
55. Djamali A., Vidyasagar A., Yagci G., Huang L.J., Reese S. Mycophenolic acid may delay allograft fibrosis by inhibiting transforming growth factor-beta1-induced activation of Nox-2 through the nuclear factor-kappaB pathway. Transplantation 2010, 90:387-393.
56. Jang H.S., Kim J.I., Jung K.J., Kim J., Han K.H., Park K.M. Bone marrow-derived cells play a major role in kidney fibrosis via proliferation and differentiation in the infiltrated site. Biochim. Biophys. Acta 2013, 1832:817-825.